Status:
UNKNOWN
Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Nasopharyngeal Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
18F-FDG PET, a whole-body imaging technology based on glucose metabolism, can effectively detect subclinical and clinical therapeutic responses at stages that are earlier than those detected by conven...
Detailed Description
In order to improve locoregional control and to eradicate micrometastases for patients with locally advanced nasopharyngeal carcinoma (NPC), induction chemotherapy followed by concurrent chemoradiothe...
Eligibility Criteria
Inclusion
- newly diagnosed locally advanced NPC patients who are receiving induction chemotherapy for treatment
Exclusion
- age below 18 year old
- pregnancy women
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00304694
Start Date
March 1 2006
Last Update
March 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taipei, Taiwan, 10012